跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
PRADAXA 150 MG CAPSULAS DURAS
Approved
STANDARD
PRADAXA 150 MG CAPSULAS DURAS
Boehringer Ingelheim International Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 29, 2025
Approval ID
a711cbfe2d7fafed
Company
Boehringer Ingelheim International Gmbh
Type
Standard
Approval Details
Approval Id
a711cbfe2d7fafed
Drug Cima Aemps Name
PRADAXA 150 MG CAPSULAS DURAS
Register Number
08442011IP
Holder Company Name
Boehringer Ingelheim International Gmbh
Marketing Company Name
Difarmed S.L.U.
Holder Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Authorization Date
2025-10-29
Dosage Form
CÁPSULA DURA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Boehringer Ingelheim International Gmbh
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Company Information
Pharmaceutical Company Name
Boehringer Ingelheim International GmbH
Country Name
Germany
City Name
ingelheim am rhein,rheinland-pfalz,country_de
Address
Binger Straße 173
Website
http://www.boehringer-ingelheim.com
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 29, 2025
Approval ID
a711cbfe2d7fafed
Type
Standard
Back to CIMA-AEMPS Approvals
PRADAXA 150 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details